| MAN JAPAN COREALPHA EQUITY D H EUR | RVI JAPÓN | 555,040000 | 02/11/2026 | 19,48% | 101,61% | ***** |
| NEUBERGER BERMAN US SMALL CAP USD I DIS | RVI USA SMALL/MID CAP | 23,885521 | 02/11/2026 | 19,48% | 28,22% | * |
| PRIVILEDGE - AMERICAN CENTURY EMERGING MARKETS EQUITY (USD) M CAP | RVI EMERGENTES | 14,258850 | 30/10/2026 | 19,48% | 77,51% | **** |
| PRIVILEDGE - AMERICAN CENTURY EMERGING MARKETS EQUITY (USD) M DIS | RVI EMERGENTES | 13,653100 | 30/10/2026 | 19,48% | 73,68% | **** |
| STATE STREET SPDR MSCI EMERGING MARKETS UCITS ETF | RVI EMERGENTES | 86,335235 | 02/11/2026 | 19,48% | 72,18% | *** |
| THE JUPITER GLOBAL FUND - JUPITER JAPAN SELECT L GBP A INC | RVI JAPÓN | 44,831299 | 02/11/2026 | 19,48% | 53,97% | ** |
| UBS (LUX) EQUITY SICAV - EUROPEAN INCOME OPPORTUNITY (EUR) Q-ACC | RVI EUROPA | 167,670000 | 30/10/2026 | 19,48% | 64,50% | ***** |
| AMUNDI FUNDS EUROPEAN EQUITY VALUE A USD HGD (C) | RVI EUROPA VALOR | 91,690442 | 02/11/2026 | 19,47% | 58,56% | *** |
| ARTEMIS US EXTENDED ALPHA I ACC GBP HEDGED | RVI USA | 4,456329 | 02/11/2026 | 19,47% | · | ND |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | RVI BIOTECNOLOGÍA | 1.195,230029 | 02/11/2026 | 19,47% | 81,41% | *** |
